Please ensure Javascript is enabled for purposes of website accessibility

FDA commissioner

US Food and Drug Administration Commissioner Marty Makary speaks during a press conference at the Department of Health and Human Services in Washington, D.C., U.S., November 10, 2025. REUTERS/Elizabeth Frantz/File Photo
May 13, 2026

Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms

FDA commissioner Dr. Marty Makary's departure may boost biotech sentiment temporarily but leaves a leadership vacuum at the agency, raising industry concerns.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.